Abstract
We review the radiobiological principles underlying stereotactic radiation therapy (SRT) and their clinical applications to single- and multi-fraction radiotherapy—both for malignant tumors, benign tumors, and vascular disorders. The classic radiobiological phenomena of repair, reoxygenation, and repopulation (the three Rs) are discussed, as well as their relationship to cell death, a clearly important mechanism by which radiotherapy produces both tumor control and normal tissue complications. Mechanistic models of radiotherapeutic response are useful for calculating isoeffect relationships for alternate fractionation schemes and for understanding the underlying biophysical mechanisms of radiation response. The linear–quadratic (LQ) formalism, which models the three Rs, is now almost universally used for isoeffect calculations of different fractionation and protraction schemes. While other radiobiological mechanisms at high doses per fraction have been shown in the laboratory, there is to date no clinical evidence of their relevance to SRT response, and the LQ model appears to be appropriate for use at all the doses and fractionation schemes of relevance to SRT. Rather than new biological mechanisms, recent analyses of clinical data suggest that the great success of SRT is primarily related to its improved conformal dose delivery that permits significant escalation of the biologically effective doses.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
1 (The term “stereotactic radiation therapy” will be used here to apply both to single-fraction treatment (often called radiosurgery) and to multi-fraction stereotactic radiotherapy (often called stereotactic body radiation therapy when applied to extracranial sites). There is still debate about the most appropriate terminology [2–4]).
References
Leksell L. Cerebral radiosurgery. I. Gammathalanotomy in two cases of intractable pain. Acta Chir Scand. 1968;134(8):585–95.
Lunsford LD, Flickinger JC, Larson D. Regarding: Rosenthal DI, Glatstein E. “We’ve got a treatment, but what’s the disease?” The Oncologist 1996;1. Oncologist. 1997;2(1):59–61.
Adler Jr JR, Colombo F, Heilbrun MP, Winston K. Toward an expanded view of radiosurgery. Neurosurgery. 2004;55(6):1374–6.
Loo BW, Chang JY, Dawson LA, Kavanagh BD, Koong AC, Senan S, et al. Stereotactic ablative radiotherapy: what’s in a name? Pract Radiat Oncol. 2011;1(1):38–9.
Colombo F, Benedetti A, Pozza F, Avanzo RC, Marchetti C, Chierego G, et al. External stereotactic irradiation by linear accelerator. Neurosurgery. 1985;16(2):154–60.
Houdek PV, Fayos JV, Van Buren JM, Ginsberg MS. Stereotaxic radiotherapy technique for small intracranial lesions. Med Phys. 1985;12(4):469–72.
Chen JC, Rahimian J, Girvigian MR, Miller MJ. Contemporary methods of radiosurgery treatment with the Novalis linear accelerator system. Neurosurg Focus. 2007;23(6):E4. Epub 2007/12/18.
Dhabaan A, Elder E, Schreibmann E, Crocker I, Curran WJ, Oyesiku NM, et al. Dosimetric performance of the new high-definition multileaf collimator for intracranial stereotactic radiosurgery. J Appl Clin Med Phys. 2010;11(3):3040. Epub 2010/08/19.
Roa DE, Schiffner DC, Zhang J, Dietrich SN, Kuo JV, Wong J, et al. The use of RapidArc volumetric-modulated arc therapy to deliver stereotactic radiosurgery and stereotactic body radiotherapy to intracranial and extracranial targets. Med Dosim. 2012;37(3):257–64. Epub 2012/03/01.
Adler Jr JR, Chang SD, Murphy MJ, Doty J, Geis P, Hancock SL. The Cyberknife: a frameless robotic system for radiosurgery. Stereotact Funct Neurosurg. 1997;69(1–4 Pt 2):124–8.
Chen CC, Chapman P, Petit J, Loeffler J. Proton radiosurgery in neurosurgery. Neurosurg Focus. 2007;23(6):E5. Epub 2007/12/18.
Halasz LM, Bussiere MR, Dennis ER, Niemierko A, Chapman PH, Loeffler JS, et al. Proton stereotactic radiosurgery for the treatment of benign meningiomas. Int J Radiat Oncol Biol Phys. 2011;81(5):1428–35. Epub 2010/10/12.
Zimmermann F, Wulf J, Lax I, Nagata Y, Timmerman RD, Stojkovski I, et al. Stereotactic body radiation therapy for early non-small cell lung cancer. Front Radiat Ther Oncol. 2010;42:94–114. Epub 2009/12/04.
Schwade JG, Houdek PV, Landy HJ, Bujnoski JL, Lewin AA, Abitol AA, et al. Small-field stereotactic external-beam radiation therapy of intracranial lesions: fractionated treatment with a fixed-halo immobilization device. Radiology. 1990;176(2):563–5.
Souhami L, Olivier A, Podgorsak EB, Villemure JG, Pla M, Sadikot AF. Fractionated stereotactic radiation therapy for intracranial tumors. Cancer. 1991;68(10):2101–8.
Simonova G, Novotny J, Novotny Jr J, Vladyka V, Liscak R. Fractionated stereotactic radiotherapy with the Leksell Gamma Knife: feasibility study. Radiother Oncol. 1995;37(2):108–16. Epub 1995/11/01.
Regine WF, Patchell RA, Strottmann JM, Meigooni A, Sanders M, Young B. Combined stereotactic split-course fractionated gamma knife radiosurgery and conventional radiation therapy for unfavorable gliomas: a phase I study. J Neurosurg. 2000;93 Suppl 3:37–41. Epub 2001/01/06.
Higuchi Y, Serizawa T, Nagano O, Matsuda S, Ono J, Sato M, et al. Three-staged stereotactic radiotherapy without whole brain irradiation for large metastatic brain tumors. Int J Radiat Oncol Biol Phys. 2009;74(5):1543–8. Epub 2009/01/13.
Ernst-Stecken A, Ganslandt O, Lambrecht U, Sauer R, Grabenbauer G. Phase II trial of hypofractionated stereotactic radiotherapy for brain metastases: results and toxicity. Radiother Oncol. 2006;81(1):18–24. Epub 2006/09/19.
Narayana A, Chang J, Yenice K, Chan K, Lymberis S, Brennan C, et al. Hypofractionated stereotactic radiotherapy using intensity-modulated radiotherapy in patients with one or two brain metastases. Stereotact Funct Neurosurg. 2007;85(2–3):82–7. Epub 2006/12/15.
Mori Y, Hashizume C, Kobayashi T, Shibamoto Y, Kosaki K, Nagai A. Stereotactic radiotherapy using Novalis for skull base metastases developing with cranial nerve symptoms. J Neurooncol. 2010;98(2):213–9. Epub 2010/04/21.
Matsuyama T, Kogo K, Oya N. Clinical outcomes of biological effective dose-based fractionated stereotactic radiation therapy for metastatic brain tumors from non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2013;85:984–90. Epub 2012/10/25.
Hattangadi JA, Chapman PH, Bussiere MR, Niemierko A, Ogilvy CS, Rowell A, et al. Planned two-fraction proton beam stereotactic radiosurgery for high-risk inoperable cerebral arteriovenous malformations. Int J Radiat Oncol Biol Phys. 2012;83(2):533–41. Epub 2011/11/22.
Gill SS, Thomas DG, Warrington AP, Brada M. Relocatable frame for stereotactic external beam radiotherapy. Int J Radiat Oncol Biol Phys. 1991;20(3):599–603.
Kooy HM, Dunbar SF, Tarbell NJ, Mannarino E, Ferarro N, Shusterman S, et al. Adaptation and verification of the relocatable Gill-Thomas-Cosman frame in stereotactic radiotherapy. Int J Radiat Oncol Biol Phys. 1994;30(3):685–91.
Kamath R, Ryken TC, Meeks SL, Pennington EC, Ritchie J, Buatti JM. Initial clinical experience with frameless radiosurgery for patients with intracranial metastases. Int J Radiat Oncol Biol Phys. 2005;61(5):1467–72.
Verellen D, Soete G, Linthout N, Van Acker S, De Roover P, Vinh-Hung V, et al. Quality assurance of a system for improved target localization and patient set-up that combines real-time infrared tracking and stereoscopic X-ray imaging. Radiother Oncol. 2003;67(1):129–41. Epub 2003/05/22.
Overgaard J, Horsman MR. Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and sensitizers. Semin Radiat Oncol. 1996;6(1):10–21.
Rijken PF, Peters JP, Van der Kogel AJ. Quantitative analysis of varying profiles of hypoxia in relation to functional vessels in different human glioma xenograft lines. Radiat Res. 2002;157(6): 626–32.
Powers WE, Tolmach LJ. A multicomponent x-ray survival curve for mouse lymphosarcoma cells irradiated in vivo. Nature. 1963;197:710–1.
Leith JT, Cook S, Chougule P, Calabresi P, Wahlberg L, Lindquist C, et al. Intrinsic and extrinsic characteristics of human tumors relevant to radiosurgery: comparative cellular radiosensitivity and hypoxic percentages. Acta Neurochir Suppl. 1994;62:18–27.
Hall EJ. Radiobiology for the radiologist. 5th ed. Philadelphia: Lippincott, Williams & Wilkins; 2000.
Carlson DJ, Stewart RD, Semenenko VA. Effects of oxygen on intrinsic radiation sensitivity: a test of the relationship between aerobic and hypoxic linear-quadratic (LQ) model parameters. Med Phys. 2006;33(9):3105–15. Epub 2006/10/07.
Carlson DJ, Keall PJ, Loo Jr BW, Chen ZJ, Brown JM. Hypofractionation results in reduced tumor cell kill compared to conventional fractionation for tumors with regions of hypoxia. Int J Radiat Oncol Biol Phys. 2011;79(4):1188–95. Epub 2010/12/25.
Carlson DJ, Yenice KM, Orton CG. Tumor hypoxia is an important mechanism of radioresistance in hypofractionated radiotherapy and must be considered in the treatment planning process. Med Phys. 2011;38(12):6347–50. Epub 2011/12/14.
Brenner DJ, Hall EJ. Conditions for the equivalence of continuous to pulsed low dose rate brachytherapy. Int J Radiat Oncol Biol Phys. 1991;20(1):181–90.
Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol. 1989;62(740):679–94.
Thames HD, Hendry JH. Fractionation in radiotherapy. London: Taylor & Francis; 1987. p. ix, 297.
Thames HD, Bentzen SM, Turesson I, Overgaard M, van den Bogaert W. Fractionation parameters for human tissues and tumors. Int J Radiat Biol. 1989;56(5):701–10.
Withers HR, Thames Jr HD, Flow BL, Mason KA, Hussey DH. The relationship of acute to late skin injury in 2 and 5 fraction/week gamma-ray therapy. Int J Radiat Oncol Biol Phys. 1978;4(7–8):595–601.
Withers HR, Taylor JM, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol. 1988;27(2):131–46.
Brenner DJ. Accelerated repopulation during radiotherapy—evidence for delayed onset. Radiat Oncol Invest. 1993;1:167–72.
Slevin NJ, Hendry JH, Roberts SA, Agren-Cronqvist A. The effect of increasing the treatment time beyond three weeks on the control of T2 and T3 laryngeal cancer using radiotherapy. Radiother Oncol. 1992;24(4):215–20.
Dasu A, Fowler JF. Comments on “Comparison of in vitro and in vivo alpha/beta ratios for prostate cancer”. Phys Med Biol. 2005;50(6):L1–4; author reply L5–8. Epub 2006/09/28.
Saunders MI, Dische S, Grosch EJ, Fermont DC, Ashford RF, Maher EJ, et al. Experience with CHART. Int J Radiat Oncol Biol Phys. 1991;21(3):871–8.
Hall EJ, Brenner DJ. The radiobiology of radiosurgery: rationale for different treatment regimes for AVMs and malignancies. Int J Radiat Oncol Biol Phys. 1993;25(2):381–5.
Loeffler JS, Kooy HM, Wen PY, Fine HA, Cheng CW, Mannarino EG, et al. The treatment of recurrent brain metastases with stereotactic radiosurgery. J Clin Oncol. 1990;8(4):576–82.
Ogilvy CS. Radiation therapy for arteriovenous malformations: a review. Neurosurgery. 1990;26(5):725–35.
Friedman WA, Bova FJ. Radiosurgery for arteriovenous malformations. Neurol Res. 2011;33(8):803–19. Epub 2011/10/19.
Barr JC, Ogilvy CS. Selection of treatment modalities or observation of arteriovenous malformations. Neurosurg Clin N Am. 2012;23(1):63–75. Epub 2011/11/24.
See AP, Raza S, Tamargo RJ, Lim M. Stereotactic radiosurgery of cranial arteriovenous malformations and dural arteriovenous fistulas. Neurosurg Clin N Am. 2012;23(1):133–46. Epub 2011/11/24.
Kjellberg RN, Hanamura T, Davis KR, Lyons SL, Adams RD. Bragg-peak proton-beam therapy for arteriovenous malformations of the brain. N Engl J Med. 1983;309(5):269–74.
Marks LB, Spencer DP. The influence of volume on the tolerance of the brain to radiosurgery. J Neurosurg. 1991;75(2):177–80.
Nedzi LA, Kooy H, Alexander III E, Gelman RS, Loeffler JS. Variables associated with the development of complications from radiosurgery of intracranial tumors. Int J Radiat Oncol Biol Phys. 1991;21(3):591–9.
Sheline GE, Wara WM, Smith V. Therapeutic irradiation and brain injury. Int J Radiat Oncol Biol Phys. 1980;6(9):1215–28.
Wowra B, Schmitt HP, Sturm V. Incidence of late radiation necrosis with transient mass effect after interstitial low dose rate radiotherapy for cerebral gliomas. Acta Neurochir (Wien). 1989; 99(3–4):104–8.
Touboul E, Al Halabi A, Buffat L, Merienne L, Huart J, Schlienger M, et al. Single-fraction stereotactic radiotherapy: a dose-response analysis of arteriovenous malformation obliteration. Int J Radiat Oncol Biol Phys. 1998;41(4):855–61.
Flickinger JC, Kondziolka D, Maitz AH, Lunsford LD. An analysis of the dose-response for arteriovenous malformation radiosurgery and other factors affecting obliteration. Radiother Oncol. 2002;63(3):347–54.
Kocher M, Wilms M, Makoski HB, Hassler W, Maarouf M, Treuer H, et al. Alpha/beta ratio for arteriovenous malformations estimated from obliteration rates after fractionated and single-dose irradiation. Radiother Oncol. 2004;71(1):109–14.
Mayer A, Hockel M, Wree A, Leo C, Horn LC, Vaupel P. Lack of hypoxic response in uterine leiomyomas despite severe tissue hypoxia. Cancer Res. 2008;68(12):4719–26. Epub 2008/06/19.
Shrieve DC, Hazard L, Boucher K, Jensen RL. Dose fractionation in stereotactic radiotherapy for parasellar meningiomas: radiobiological considerations of efficacy and optic nerve tolerance. J Neurosurg. 2004;101 Suppl 3:390–5.
Goldsmith BJ, Rosenthal SA, Wara WM, Larson DA. Optic neuropathy after irradiation of meningioma. Radiology. 1992;185(1): 71–6.
Bhandare N, Monroe AT, Morris CG, Bhatti MT, Mendenhall WM. Does altered fractionation influence the risk of radiation-induced optic neuropathy? Int J Radiat Oncol Biol Phys. 2005;62(4):1070–7.
Dale RG. The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy. Br J Radiol. 1985;58(690):515–28.
Lea DE. Actions of radiation on living cells. Cambridge: University Press; 1946.
Sachs RK, Hahnfeld P, Brenner DJ. The link between low-LET dose-response relations and the underlying kinetics of damage production/repair/misrepair. Int J Radiat Biol. 1997;72(4): 351–74.
Ellis F. Is NSD-TDF useful to radiotherapy? Int J Radiat Oncol Biol Phys. 1985;11(9):1685–97.
Turesson I, Notter G. Skin reaction as a biological parameter for prospective studies of different dose schedules with the CRE formula. Bull Cancer. 1976;63(1):11–26.
Bates TD, Peters LJ. Dangers of the clinical use of the NSD formula for small fraction numbers. Br J Radiol. 1975;48(573):773.
Peters LJ, Withers HR. Morbidity from large dose fractions in radiotherapy. Br J Radiol. 1980;53(626):170–1.
Gerweck LE, Zaidi ST, Zietman A. Multivariate determinants of radiocurability. I: prediction of single fraction tumor control doses. Int J Radiat Oncol Biol Phys. 1994;29(1):57–66.
Brown M, Bristow R, Glazer P, Hill R, McBride W, McKenna G, et al. Comment on “Tumor response to radiotherapy regulated by endothelial cell apoptosis” (II). Science. 2003;302(5652):1894; author reply.
Carlson DJ, Stewart RD, Semenenko VA, Sandison GA. Combined use of Monte Carlo DNA damage simulations and deterministic repair models to examine putative mechanisms of cell killing. Radiat Res. 2008;169(4):447–59. Epub 2008/03/28.
Preston RJ. Mechanisms of induction of specific chromosomal alterations. Basic Life Sci. 1990;53:329–36.
Wlodek D, Hittelman WN. The relationship of DNA and chromosome damage to survival of synchronized X-irradiated L5178Y cells. II. Repair. Radiat Res. 1988;115(3):566–75.
Savage JR. A brief survey of aberration origin theories. Mutat Res. 1998;404(1–2):139–47.
Lea DE, Catcheside DG. The mechanism of the induction by radiation of chromosome aberrations in tradescantia. J Genet. 1942;44:216–45.
Kellerer AM, Rossi HH. The theory of dual radiation action. Curr Top Radiat Res. 1972;8:85–158.
Frankenberg D, Brede HJ, Schrewe UJ, Steinmetz C, Frankenberg-Schwager M, Kasten G, et al. Induction of DNA double-strand breaks by 1H and 4He lons in primary human skin fibroblasts in the LET range of 8 to 124 keV/microm. Radiat Res. 1999;151(5):540–9.
Frankenberg-Schwager M. Induction, repair and biological relevance of radiation-induced DNA lesions in eukaryotic cells. Radiat Environ Biophys. 1990;29(4):273–92.
Rothkamm K, Lobrich M. Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses. Proc Natl Acad Sci U S A. 2003;100(9):5057–62.
Sutherland BM, Bennett PV, Schenk H, Sidorkina O, Laval J, Trunk J, et al. Clustered DNA damages induced by high and low LET radiation, including heavy ions. Phys Med. 2001;17 Suppl 1:202–4.
Thames HD. An ‘incomplete-repair’ model for survival after fractionated and continuous irradiations. Int J Radiat Biol. 1985;47(3):319–39.
Brenner DJ, Huang Y, Hall EJ. Fractionated high dose-rate versus low dose-rate regimens for intracavitary brachytherapy of the cervix: equivalent regimens for combined brachytherapy and external irradiation. Int J Radiat Oncol Biol Phys. 1991;21(6):1415–23.
Wang JZ, Li XA, D’Souza WD, Stewart RD. Impact of prolonged fraction delivery times on tumor control: a note of caution for intensity-modulated radiation therapy (IMRT). Int J Radiat Oncol Biol Phys. 2003;57(2):543–52. Epub 2003/09/06.
Carlson DJ, Stewart RD, Li XA, Jennings K, Wang JZ, Guerrero M. Comparison of in vitro and in vivo alpha/beta ratios for prostate cancer. Phys Med Biol. 2004;49(19):4477–91. Epub 2004/11/24.
Webb S, Nahum AE. A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density. Phys Med Biol. 1993;38(6):653–66. Epub 1993/06/01.
Tome WA, Fowler JF. On the inclusion of proliferation in tumour control probability calculations for inhomogeneously irradiated tumours. Phys Med Biol. 2003;48(18):N261–8. Epub 2003/10/08.
Keall PJ, Webb S. Optimum parameters in a model for tumour control probability, including interpatient heterogeneity: evaluation of the log-normal distribution. Phys Med Biol. 2007;52(1):291–302. Epub 2006/12/22.
Fowler JF, Ritter MA, Chappell RJ, Brenner DJ. What hypofractionated protocols should be tested for prostate cancer? Int J Radiat Oncol Biol Phys. 2003;56(4):1093–104.
Prevost JB, Voet P, Hoogeman M, Praag J, Levendag P, Nuyttens JJ. Four-dimensional stereotactic radiotherapy for early stage non-small cell lung cancer: a comparative planning study. Technol Cancer Res Treat. 2008;7(1):27–34.
Brenner DJ, Martel MK, Hall EJ. Fractionated regimens for stereotactic radiotherapy of recurrent tumors in the brain. Int J Radiat Oncol Biol Phys. 1991;21(3):819–24.
Brenner DJ. The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction. Semin Radiat Oncol. 2008;18(4):234–9.
Bartkowiak D, Hogner S, Nothdurft W, Rottinger EM. Cell cycle and growth response of CHO cells to X-irradiation: threshold-free repair at low doses. Int J Radiat Oncol Biol Phys. 2001;50(1): 221–7.
Garcia LM, Leblanc J, Wilkins D, Raaphorst GP. Fitting the linear-quadratic model to detailed data sets for different dose ranges. Phys Med Biol. 2006;51(11):2813–23.
Barendsen GW. Dose fractionation, dose rate and iso-effect relationships for normal tissue responses. Int J Radiat Oncol Biol Phys. 1982;8(11):1981–97.
van der Kogel AJ. Chronic effects of neutrons and charged particles on spinal cord, lung, and rectum. Radiat Res Suppl. 1985;8:S208–16.
Douglas BG, Fowler JF. The effect of multiple small doses of x rays on skin reactions in the mouse and a basic interpretation. Radiat Res. 1976;66(2):401–26.
Peck JW, Gibbs FA. Mechanical assay of consequential and primary late radiation effects in murine small intestine: alpha/beta analysis. Radiat Res. 1994;138(2):272–81.
Taylor JM, Kim DK. The poor statistical properties of the Fe-plot. Int J Radiat Biol. 1989;56(2):161–7.
de Boer RW. The use of the D versus dD plot to estimate the alpha/beta ratio from iso-effect radiation damage data. Radiother Oncol. 1988;11(4):361–7.
Tucker SL. Tests for the fit of the linear-quadratic model to radiation isoeffect data. Int J Radiat Oncol Biol Phys. 1984;10(10): 1933–9.
Ling CC, Chen CH, Fuks Z. An equation for the dose response of radiation-induced apoptosis: possible incorporation with the LQ model. Radiother Oncol. 1994;33(1):17–22.
Brenner DJ, Hlatky LR, Hahnfeldt PJ, Huang Y, Sachs RK. The linear-quadratic model and most other common radiobiological models result in similar predictions of time-dose relationships. Radiat Res. 1998;150(1):83–91.
Curtis SB. Lethal and potentially lethal lesions induced by radiation–a unified repair model. Radiat Res. 1986;106(2): 252–70.
Hawkins RB. A microdosimetric-kinetic model of cell death from exposure to ionizing radiation of any LET, with experimental and clinical applications. Int J Radiat Biol. 1996;69(6):739–55.
Obaturov GM, Moiseenko VV, Filimonov AS. Model of mammalian cell reproductive death. I. Basic assumptions and general equations. Radiat Environ Biophys. 1993;32(4):285–94.
Tobias CA. The repair-misrepair model in radiobiology: comparison to other models. Radiat Res Suppl. 1985;8:S77–95.
Zaider M. There is no mechanistic basis for the use of the linear-quadratic expression in cellular survival analysis. Med Phys. 1998;25(5):791–2.
Sachs RK, Brenner DJ. The mechanistic basis of the linear-quadratic formalism. Med Phys. 1998;25(10):2071–3.
Kiefer J. A repair fixation model. In: Kiefer J, editor. Quantitative mathematical models in radiation biology. New York: Springer; 1988.
Haynes RH. The interpretation of microbial inactivation and recovery phenomena. Radiat Res. 1966;(Suppl 6):1–29.
Laurie J, Orr JS, Foster CJ. Repair processes and cell survival. Br J Radiol. 1972;45(533):362–8.
Reddy NM, Mayer PJ, Lange CS. The saturated repair kinetics of Chinese hamster V79 cells suggests a damage accumulation–interaction model of cell killing. Radiat Res. 1990;121(3): 304–11.
Sontag W. A cell survival model with saturable repair after irradiation. Radiat Environ Biophys. 1987;26(1):63–79.
Ward JF, Limoli CL, Calabro-Jones PM, Aguilera J. An examination of the repair saturation hypothesis for describing shouldered survival curves. Radiat Res. 1991;127(1):90–6.
Kirkpatrick JP, Meyer JJ, Marks LB. The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. Semin Radiat Oncol. 2008;18(4):240–3. Epub 2008/08/30.
Garcia-Barros M, Paris F, Cordon-Cardo C, Lyden D, Rafii S, Haimovitz-Friedman A, et al. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science. 2003;300(5622): 1155–9. Epub 2003/05/17.
Yamada Y, Bilsky MH, Lovelock DM, Venkatraman ES, Toner S, Johnson J, et al. High-dose, single-fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions. Int J Radiat Oncol Biol Phys. 2008;71(2):484–90. Epub 2008/02/01.
Postow MA, Callahan MK, Barker CA, Yamada Y, Yuan J, Kitano S, et al. Immunologic correlates of the abscopal effect in a patient with melanoma. N Engl J Med. 2012;366(10):925–31. Epub 2012/03/09.
Hiniker SM, Chen DS, Knox SJ. Abscopal effect in a patient with melanoma. N Engl J Med. 2012;366(21):2035; author reply 2036. Epub 2012/05/25.
Brown JM, Koong AC. High-dose single-fraction radiotherapy: exploiting a new biology? Int J Radiat Oncol Biol Phys. 2008;71(2):324–5. Epub 2008/05/14.
Brown JM, Brenner DJ, Carlson DJ. Dose escalation, not “new biology,” can account for the efficacy of stereotactic body radiation therapy with non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2013;85(5):1159–60.
Brown JM, Carlson DJ, Brenner DJ. The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved? Int J Radiat Oncol Biol Phys. 2014;88(2):254–62.
Mehta N, King CR, Agazaryan N, Steinberg M, Hua A, Lee P. Stereotactic body radiation therapy and 3-dimensional conformal radiotherapy for stage I non-small cell lung cancer: a pooled analysis of biological equivalent dose and local control. Pract Radiat Oncol. 2012;2:288–95.
Lo SS, Fakiris AJ, Chang EL, Mayr NA, Wang JZ, Papiez L, et al. Stereotactic body radiation therapy: a novel treatment modality. Nat Rev Clin Oncol. 2010;7(1):44–54. Epub 2009/12/10.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Brenner, D.J., Carlson, D.J. (2015). Radiobiological Principles Underlying Stereotactic Radiation Therapy. In: Chin, L., Regine, W. (eds) Principles and Practice of Stereotactic Radiosurgery. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8363-2_5
Download citation
DOI: https://doi.org/10.1007/978-1-4614-8363-2_5
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-8362-5
Online ISBN: 978-1-4614-8363-2
eBook Packages: MedicineMedicine (R0)